Intelligent system for noninvasive blood analyte prediction
AssigneeInstrumentation Metrics, Inc.
InventorsStephen F. Malin, Timothy L. Ruchti
Life of this patent
Estimating the term…
Loading patent…
AssigneeInstrumentation Metrics, Inc.
InventorsStephen F. Malin, Timothy L. Ruchti
Estimating the term…
An intelligent system for measuring blood analytes noninvasively operates on a near infrared absorbance spectrum of in vivo skin tissue. An hierarchical architecture employs a pattern classification engine to adapt the calibration to the structural properties and physiological state of the subject as manifested in the absorbance spectrum. A priori information about the primary sources of sample variability are used to establish general categories of subjects. By applying calibration schemes specific to the various categories, the spectral interference is reduced resulting in improved prediction accuracy and parsimonious calibrations. Two classification rules are disclosed. The first rule assumes the classes are mutually exclusive and applies specific calibration models to the various subject categories. The second rule uses fuzzy set theory to develop calibration models and blood analyte predictions. Therefore, each calibration sample has the opportunity to influence more than one calibration model according to its class membership. Similarly, the predictions from more than one calibration are combined through defuzzification to produce the final blood analyte prediction.
A method for compensating for covariation of spectrally interfering species, sample heterogeneity, state variations, and structural variations, comprising the steps of:
An intelligent system for measuring blood analytes noninvasively by operating on a near infrared (NIR) absorbance spectrum of in vivo skin tissue, said system comprising:
An intelligent system for measuring blood analytes noninvasively by operating on a near infrared (NIR) absorbance spectrum of in vivo skin tissue, said system comprising:
A pattern recognition method for estimating a concentration of a target blood analyte, comprising the step of:
Dependencies are inferred from the claim text.